Health Times Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Times Virgin Islands.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 2, 2026

Mar. 2, 2026

MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

Mar. 2, 2026

Alignment Healthcare Announces Secondary Offering

GlobeNewswire

Mar. 2, 2026

BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase

GlobeNewswire

Mar. 2, 2026

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 2, 2026

Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026

GlobeNewswire

Mar. 2, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 2, 2026

Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance

GlobeNewswire

Mar. 2, 2026

Immuneering to Present at the Leerink Global Healthcare Conference

GlobeNewswire

Mar. 2, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 2, 2026

Myriad Commercially Launches Precise MRD with Select Community Oncologists

GlobeNewswire

Mar. 2, 2026

Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates

GlobeNewswire

Mar. 2, 2026

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 2, 2026

Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2025 Results; Sets 2026 Guidance; Announces Share Repurchase Program

GlobeNewswire

Mar. 2, 2026

Tenaya Therapeutics to Participate in the Leerink Partners Global Healthcare Conference 2026

GlobeNewswire

Mar. 2, 2026

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

Mar. 2, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 2, 2026

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

Mar. 2, 2026

Cytokinetics to Participate in March Investor Conferences

GlobeNewswire

Mar. 2, 2026

RadNet, Inc. to Present at the Raymond James 47th Annual Institutional Investors Conference on Tuesday, March 3rd, 2026

GlobeNewswire

Mar. 2, 2026

CMMB Partners with Healey International Relief Foundation to Expand Noncommunicable Disease Care

GlobeNewswire